Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

IRB

Showing results (341-350 of 778) with videos related to

Pageof 78
Sort By:
IRB|September 15, 2007
Evaluating the risks and benefits of phase II and III cancer clinical trials: a look at Institutional Review Board members in the NetherlandsH E M Van Luijn, A W Musschenga, R B Keus, et al.
IRB|September 13, 2007
Ethical issues in cancer chemoprevention trials: considerations for IRBs and investigatorsJulia Slutsman, David Buchanan, Christine Grady
IRB|September 13, 2007
Determining the costs of Institutional Review BoardsJeanne L Speckman, Margaret M Byrne, Jason Gerson, et al.
IRB|September 13, 2007
Monitoring reportable events and unanticipated problems: the PHAROS and PREDICT studies of Huntington diseaseCheryl Erwin, Steven Hersch,
IRB|August 25, 2009
A consent form template for phase I oncology trialsShlomo A Koyfman, Mary S McCabe, Ezekiel J Emanuel, et al.
IRB|August 25, 2009
Financial conflicts and clinical researchKarin Meyers
IRB|April 9, 2010
OHRP compliance oversight letters: an updateCarol Weil, Lisa Rooney, Patrick McNeilly, et al.
IRB|April 9, 2010
Genetic research with stored biological materials: ethics and practiceLeslie E Wolf, Timothy A Bouley, Charles E McCulloch
IRB|February 18, 2012
Money, coercion, and undue inducement: attitudes about payments to research participantsEmily A Largent, Christine Grady, Franklin G Miller, et al.
IRB|February 18, 2012
Clarity and appeal of a multimedia informed consent tool for biobankingSarah A McGraw, Carol A Wood-Nutter, Mildred Z Solomon, et al.
Pageof 78

Showing results (341-350 of 778) with videos related to

Sort By:
Pageof 78
IRB|September 15, 2007
Evaluating the risks and benefits of phase II and III cancer clinical trials: a look at Institutional Review Board members in the NetherlandsH E M Van Luijn, A W Musschenga, R B Keus, et al.
IRB|September 13, 2007
Ethical issues in cancer chemoprevention trials: considerations for IRBs and investigatorsJulia Slutsman, David Buchanan, Christine Grady
IRB|September 13, 2007
Determining the costs of Institutional Review BoardsJeanne L Speckman, Margaret M Byrne, Jason Gerson, et al.
IRB|September 13, 2007
Monitoring reportable events and unanticipated problems: the PHAROS and PREDICT studies of Huntington diseaseCheryl Erwin, Steven Hersch,
IRB|August 25, 2009
A consent form template for phase I oncology trialsShlomo A Koyfman, Mary S McCabe, Ezekiel J Emanuel, et al.
IRB|August 25, 2009
Financial conflicts and clinical researchKarin Meyers
IRB|April 9, 2010
OHRP compliance oversight letters: an updateCarol Weil, Lisa Rooney, Patrick McNeilly, et al.
IRB|April 9, 2010
Genetic research with stored biological materials: ethics and practiceLeslie E Wolf, Timothy A Bouley, Charles E McCulloch
IRB|February 18, 2012
Money, coercion, and undue inducement: attitudes about payments to research participantsEmily A Largent, Christine Grady, Franklin G Miller, et al.
IRB|February 18, 2012
Clarity and appeal of a multimedia informed consent tool for biobankingSarah A McGraw, Carol A Wood-Nutter, Mildred Z Solomon, et al.
Pageof 78